Scienture Holdings, Inc. (SCNX) — 8-K Filings
All 8-K filings from Scienture Holdings, Inc.. Browse 33 Current Event Report reports with AI-powered summaries and risk analysis.
8-K Filings (33)
-
Scienture Holdings Files 8-K: Regulation FD & Financials
— Nov 18, 2025 Risk: low
Scienture Holdings, Inc. filed an 8-K on November 18, 2025, reporting events as of November 17, 2025. The filing primarily concerns Regulation FD Disclosure and - 8-K Filing — Nov 14, 2025
- 8-K Filing — Nov 13, 2025
-
Scienture Holdings, Inc. Files 8-K Report
— Oct 30, 2025 Risk: low
On October 24, 2025, Scienture Holdings, Inc. filed an 8-K report detailing other events and financial statements. The company, formerly known as TRxADE HEALTH, -
Scienture Holdings Enters Material Definitive Agreement
— Oct 24, 2025 Risk: medium
On October 20, 2025, Scienture Holdings, Inc. entered into a material definitive agreement. The filing also includes financial statements and exhibits related t -
Scienture Holdings Faces Delisting Concerns
— Oct 17, 2025 Risk: high
Scienture Holdings, Inc. (formerly TRxADE HEALTH, INC.) filed an 8-K on October 17, 2025, reporting a notice of delisting or failure to satisfy a continued list -
Scienture Holdings Enters New Agreement, Terminates Old One
— Oct 16, 2025 Risk: medium
On October 10, 2025, Scienture Holdings, Inc. entered into a material definitive agreement and simultaneously terminated a prior material definitive agreement. -
Scienture Holdings Changes Fiscal Year End
— Oct 6, 2025 Risk: low
Scienture Holdings, Inc. filed an 8-K on October 6, 2025, reporting a change in its fiscal year end to December 31st, effective October 1, 2025. The company, fo -
Scienture Holdings, Inc. Files 8-K for Material Agreement
— Oct 3, 2025 Risk: medium
On October 3, 2025, Scienture Holdings, Inc. filed an 8-K report detailing a material definitive agreement and financial statements. The company, formerly known -
Scienture Holdings, Inc. Files 8-K for Material Agreement
— Sep 23, 2025 Risk: medium
On September 19, 2025, Scienture Holdings, Inc. entered into a material definitive agreement. The filing also includes financial statements and exhibits. The co -
Scienture Holdings Enters Material Agreement, Files 8-K
— Aug 15, 2025 Risk: medium
Scienture Holdings, Inc. (formerly TRxADE HEALTH, INC.) entered into a material definitive agreement on August 13, 2025. The company also reported on unregister -
Scienture Holdings, Inc. Files 8-K for Material Agreement
— Jul 24, 2025 Risk: medium
On July 18, 2025, Scienture Holdings, Inc. entered into a material definitive agreement. The filing also includes Regulation FD disclosures and financial statem -
Scienture Holdings, Inc. Signs Material Definitive Agreement
— Jul 3, 2025 Risk: medium
On June 27, 2025, Scienture Holdings, Inc. entered into a material definitive agreement. The filing also includes financial statements and exhibits related to t -
Scienture Holdings Reports Delisting Notice, Officer Changes
— May 22, 2025 Risk: high
Scienture Holdings, Inc. filed an 8-K on May 22, 2025, reporting several key events as of May 16, 2025. These include the termination of a material definitive a -
Scienture Holdings, Inc. Files 8-K for Material Agreement
— Apr 11, 2025 Risk: medium
On April 8, 2025, Scienture Holdings, Inc. entered into a material definitive agreement. The company, formerly known as TRxADE HEALTH, INC., is incorporated in -
Scienture Holdings Enters Material Definitive Agreement
— Mar 21, 2025 Risk: medium
On March 17, 2025, Scienture Holdings, Inc. (formerly TRxADE HEALTH, INC.) entered into a material definitive agreement. The filing also includes Regulation FD -
Scienture Holdings Reports Key Corporate Events
— Mar 13, 2025 Risk: medium
Scienture Holdings, Inc. filed an 8-K on March 13, 2025, reporting on several key events that occurred on March 10, 2025. These include entering into a material -
Scienture Holdings Enters Material Definitive Agreement
— Mar 10, 2025 Risk: medium
On March 4, 2025, Scienture Holdings, Inc. entered into a material definitive agreement. The company, formerly known as TRxADE HEALTH, INC., is incorporated in -
Scienture Holdings Names New CEO, CFO Amid Director Departure
— Jan 17, 2025 Risk: medium
Scienture Holdings, Inc. announced on January 15, 2025, the departure of director Michael L. R. Goldberg and the appointment of new officers, including CEO Jona -
Scienture Holdings Faces Delisting Concerns
— Jan 8, 2025 Risk: high
Scienture Holdings, Inc. (formerly TRxADE HEALTH, INC) filed an 8-K on January 8, 2025, reporting a notice of delisting or failure to satisfy a continued listin -
Scienture Holdings Enters Material Agreement, Discloses Financial Obligations
— Nov 26, 2024 Risk: medium
Scienture Holdings, Inc. (formerly TRxADE HEALTH, INC.) entered into a material definitive agreement on November 22, 2024. The company also disclosed the creati -
Scienture Holdings Files 8-K
— Oct 11, 2024 Risk: low
Scienture Holdings, Inc. filed an 8-K on October 11, 2024, reporting an event that occurred on September 20, 2024. The filing is categorized under 'Other Events -
Scienture Holdings, Inc. Files 8-K Report
— Oct 8, 2024 Risk: low
On October 4, 2024, Scienture Holdings, Inc. filed an 8-K report to disclose information under Regulation FD and to file financial statements and exhibits. The -
Scienture Holdings Files 8-K with Bylaw Amendments
— Sep 24, 2024 Risk: low
Scienture Holdings, Inc. filed an 8-K on September 24, 2024, reporting events as of September 20, 2024. The filing indicates amendments to articles of incorpora -
TRxADE HEALTH Announces Material Agreements and Officer Changes
— Jul 31, 2024 Risk: medium
On July 25, 2024, TRxADE HEALTH, INC. entered into a material definitive agreement related to the completion of an acquisition or disposition of assets. The com -
TRxADE HEALTH, INC. Files 8-K Report
— Jul 9, 2024 Risk: low
On July 8, 2024, TRxADE HEALTH, INC. filed an 8-K report detailing "Other Events" and "Financial Statements and Exhibits." The filing does not contain specific -
TRxADE HEALTH, INC. Files 8-K: Board and Officer Changes
— Jun 20, 2024 Risk: medium
On June 17, 2024, TRxADE HEALTH, INC. filed an 8-K report detailing changes in its board of directors and executive officers. The filing includes information on -
TRxADE HEALTH Announces Board Changes and Listing Updates
— May 30, 2024 Risk: medium
TRxADE HEALTH, INC. filed an 8-K on May 23, 2024, reporting a departure of directors and the election of new ones. The company also disclosed compensatory arran -
TRxADE HEALTH Files 8-K for Financials
— May 23, 2024 Risk: low
On May 23, 2024, TRxADE HEALTH, INC. filed an 8-K report. The filing primarily concerns financial statements and exhibits, indicating a routine update rather th -
TRxADE HEALTH, INC. Files 8-K for Asset Acquisition/Disposition
— Mar 6, 2024 Risk: medium
On February 29, 2024, TRxADE HEALTH, INC. entered into a Material Definitive Agreement related to the completion of an acquisition or disposition of assets. The -
TRxADE HEALTH Enters Material Agreement, Completes Asset Acquisition
— Feb 16, 2024 Risk: medium
TRxADE HEALTH, INC. filed an 8-K on February 16, 2024, reporting an entry into a material definitive agreement and the completion of an acquisition or dispositi -
TRxADE HEALTH Files Routine 8-K, Confirms Registration Details
— Jan 17, 2024
TRxADE HEALTH, INC. filed an 8-K on January 17, 2024, reporting an event that occurred on January 16, 2024. This filing is a routine update to the SEC, primaril -
TRxADE HEALTH Files 8-K on Material Definitive Agreement; Details Undisclosed
— Jan 11, 2024
TRxADE HEALTH, INC. filed an 8-K on January 11, 2024, reporting an "Entry into a Material Definitive Agreement" on January 8, 2024. While the filing indicates a
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX